Research output per year
Research output per year
Personal profile
Expertises
Medical Oncology
Main research areas
Precision medicine; Early clinical trials; Genomic screening; Personalized oncology
Current research
Personalized medicine in Phase 1 cancer research
Fingerprint
Dive into the research topics where Ida Elisabeth Viller Tuxen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Comprehensive analysis of failure to carry out successful genomic profiling in a phase I setting
Belcaid, L., Iden, C., Jacobsen, I., Højgaard, M., Spanggaard, I., Tuxen, I. V., Mau-Sørensen, M., Lassen, U., Yde, C. W. & Rohrberg, K. S., 3 Jun 2024, In: ESMO Open. 9, 6, 103495.Research output: Contribution to journal › Letter › peer-review
-
New pathogenic germline variants identified in mesothelioma
Belcaid, L., Bertelsen, B., Wadt, K., Tuxen, I., Spanggaard, I., Højgaard, M., Benn Sørensen, J., Ravn, J., Lassen, U., Cilius Nielsen, F., Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, p. 1-8 8 p., 107172.Research output: Contribution to journal › Review › peer-review
-
Application of cell-free DNA for genomic tumor profiling: a feasibility study
Ahlborn, L. B., Rohrberg, K. S., Gabrielaite, M., Tuxen, I. V., Yde, C. W., Spanggaard, I., Santoni-Rugiu, E., Nielsen, F. C., Lassen, U., Mau-Sorensen, M. & Østrup, O., 15 Feb 2019, In: Oncotarget. 10, 14, p. 1388-1398 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Copenhagen Prospective Personalized Oncology (CoPPO) - Clinical utility of using molecular profiling to select patients to phase 1 trials
Tuxen, I. V., Rohrberg, K. S., Østrup, O., Ahlborn, L. B., Schmidt, A. Y., Spanggaard, I., Hasselby, J. P., Santoni-Rugiu, E., Yde, C. W., Mau-Soerensen, M., Nielsen, F. C. & Lassen, U., 2019, In: Clinical Cancer Research. 25, 4, p. 1239-1247 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
65 Citations (Scopus) -
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Bertelsen, B., Tuxen, I. V., Yde, C. W., Gabrielaite, M., Torp, M. H., Kinalis, S., Oestrup, O., Rohrberg, K., Spangaard, I., Santoni-Rugiu, E., Wadt, K., Mau-Sorensen, M., Lassen, U. & Nielsen, F. C., 2019, In: Genome Medicine. 4, 1, p. 13 13.Research output: Contribution to journal › Journal article › Research › peer-review
54 Citations (Scopus)